Navigation Links
Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award
Date:4/18/2011

COVINGTON, Ky., April 18, 2011 /PRNewswire/ -- Bexion Pharmaceuticals was named the Biotech Innovation Award winner at the Cincinnati USA Innovation Awards program sponsored by the Cincinnati Business Courier, the Cincinnati USA Regional Chamber and CincyTech.  The Innovation Awards celebrate outstanding innovation and the companies and people who have shown how new ideas can be developed into fuel for the regional Tri-State (Ohio/Kentucky/Indiana) economic engine.

"The Bexion team is honored to be the very first winner of the Biotech Innovation Award," stated Dr. Ray Takigiku, co-founder and CEO of Bexion.  "Cancer treatment and diagnosis is in dire need of innovation.  We believe, and the award judges appear to agree, that our approach represents an entirely new, exciting and potentially paradigm-shifting approach to the treatment of cancer."

Bexion is developing BXQ-350 nanovesicles as a potential treatment for the form of brain cancer called glioblastoma.  BXQ-350 nanovesicles have an affinity for the membrane patches that are common in many types of tumor cells including glioblastoma cells. Bexion's studies have shown effectiveness in the laboratory in multiple animal tumor models, and across a remarkable range of tumors in the test tube.

About Bexion Pharmaceuticals:Bexion Pharmaceuticals is focused on the development and commercialization of innovative cures for cancer.  Initial products are based on a patent-protected and proprietary platform technology licensed from Cincinnati Children's Hospital Medical Center.  The technology has demonstrated potential for development as therapeutics, diagnostics and surgical imaging reagents, as well as carriers for other pharmaceutical agents, such as oligonucleotides.  For more information, visit www.bexionpharma.com.For media enquiries contact:

For investor enquiries contact:Margaret van GilseChuck ScheperVP, Business Development

ChairBexion Pharmaceuticals, LLC

Bexion Pharmaceuticals, LLC632 Russell Street

632 Russell StreetCovington, KY 41011

Covington, KY 41011Phone: (513) 833-7065

Phone: (513)252-2169mvangilse@bexionpharma.com

cscheper@bexionpharma.com
'/>"/>

SOURCE Bexion Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Former FDA Commissioner Joins Bexion Pharmaceuticals Board
2. Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
3. Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
4. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
5. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
6. Amylin Pharmaceuticals Reports First Quarter Financial Results
7. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
8. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
9. Endo Pharmaceuticals to Announce First Quarter 2011 Financial Results on April 28, 2011
10. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
11. Novis Pharmaceuticals Celebrates Four Years With New Website Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):